US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine

US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine

By

The Associated Press

July 2, 2024, 10:29 AM ET

1 min read

WASHINGTON -- US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine.